1.      Friedman AH, Fahey JT. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease. Semin Perinatol. 1993;17(2):106-21.

2.      Hooper SB, Te Pas AB, Lang J, et al. Cardiovascular transition at birth: a physiological sequence. Pediatr Res. 2015;77(5):608-14.

3.      Izraelit A, Ten V, Krishnamurthy G, et al. Neonatal cyanosis: diagnostic and management challenges. ISRN Pediatr. 2011;2011:175931.

4.      Khalil M, Jux C, Rueblinger L, et al. Acute therapy of newborns with critical congenital heart disease. Transl Pediatr. 2019;8(2):114-126.

5.      Krishnan US. Approach to congenital heart disease in the neonate. Indian J Pediatr. 2002;69(6):501-5.

6.      Kutty S, Zahn EM. Interventional therapy for neonates with critical congenital heart disease. Catheter Cardiovasc Interv. 2008;72(5):663-74.

7.      Oster ME, Kim CH, Kusano AS, et al. A population-based study of the association of prenatal diagnosis with survival rate for infants with congenital heart defects. Am J Cardiol. 2014;113(6):1036-40.

8.      Penny DJ, Shekerdemian LS. Management of the neonate with symptomatic congenital heart disease. Arch Dis Child Fetal Neonatal Ed. 2001;84(3):F141-5.

9.      Rao PS. Advances in the Diagnosis and Management of Congenital Heart Disease in Children. Children (Basel). 2023;10(4):753.

10.  Riede FT, Wörner C, Dähnert I, et al. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine. Eur J Pediatr. 2010;169(8):975-81.

11.  Rudolph AM. Congenital cardiovascular malformations and the fetal circulation. Arch Dis Child Fetal Neonatal Ed. 2010;95(2):F132-6.

12.  Singh Y, Mikrou P. Use of prostaglandins in duct-dependent congenital heart conditions. Arch Dis Child Educ Pract Ed. 2018;103(3):137-140.

13.  Singh Y. Diagnosis and management of critical congenital heart defects in infants. Paediatr Child Health. 2022;32(9):332–338.

14.  Tálosi G, Katona M, Rácz K, et al. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects. J Perinat Med. 2004;32(4):368-74.

15.  Yun SW. Congenital heart disease in the newborn requiring early intervention. Korean J Pediatr. 2011;54(5):183-91.